🎉 M&A multiples are live!
Check it out!

Almirall Valuation Multiples

Discover revenue and EBITDA valuation multiples for Almirall and similar public comparables like Armata Pharmaceuticals, Galapagos, and Julphar.

Almirall Overview

About Almirall

Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.


Founded

1944

HQ

Spain
Employees

1.9K+

Website

almirall.es

Financials

LTM Revenue $1.3B

LTM EBITDA $278M

EV

$3.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Almirall Financials

As of January 2026, Almirall reported last 12-month revenue of $1.3B and EBITDA of $278M.

In the same period, Almirall generated $856M in LTM gross profit and $56.7M in net income.

See Almirall valuation multiples based on analyst estimates

Almirall P&L

In the most recent fiscal year, Almirall reported revenue of $1.2B and EBITDA of $207M.

Almirall expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Almirall valuation multiples based on analyst estimates
LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue $1.3B XXX $1.2B XXX XXX XXX
Gross Profit $856M XXX $914M XXX XXX XXX
Gross Margin 65% XXX 78% XXX XXX XXX
EBITDA $278M XXX $207M XXX XXX XXX
EBITDA Margin 21% XXX 18% XXX XXX XXX
EBIT $102M XXX $55.7M XXX XXX XXX
EBIT Margin 8% XXX 5% XXX XXX XXX
Net Profit $56.7M XXX $12.1M XXX XXX XXX
Net Margin 4% XXX 1% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Almirall Stock Performance

Almirall has current market cap of EUR 2.9B (or $3.4B), and EV of EUR 2.8B (or $3.4B).

Market Cap Evolution

Almirall Stock Data

As of February 24, 2026, Almirall's stock price is EUR 13 (or $16).

See Almirall trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$3.4B $3.4B XXX XXX XXX XXX $0.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Almirall Valuation Multiples

Almirall's trades at 2.6x EV/Revenue multiple, and 12.1x EV/EBITDA.

See valuation multiples for Almirall and 15K+ public comps

Almirall Financial Valuation Multiples

As of February 24, 2026, Almirall has market cap of $3.4B and EV of $3.4B.

Equity research analysts estimate Almirall's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Almirall has a P/E ratio of 60.3x.

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Market cap (current) $3.4B XXX $3.4B XXX XXX XXX
EV (current) $3.4B XXX $3.4B XXX XXX XXX
EV/Revenue 2.6x XXX 2.6x XXX XXX XXX
EV/EBITDA 12.1x XXX 12.1x XXX XXX XXX
EV/EBIT 32.9x XXX 32.9x XXX XXX XXX
EV/Gross Profit 3.9x XXX n/a XXX XXX XXX
P/E 60.3x XXX 60.3x XXX XXX XXX
EV/FCF 31.5x XXX 31.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Almirall Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Almirall Margins & Growth Rates

Almirall's last 12 month revenue growth is 11%

Almirall's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.5M for the same period.

Almirall's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Almirall's rule of X is 49% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Almirall and other 15K+ public comps

Almirall Operational Valuation Multiples

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue Growth 11% XXX 10% XXX XXX XXX
EBITDA Margin 21% XXX 21% XXX XXX XXX
EBITDA Growth 20% XXX 43% XXX XXX XXX
Rule of 40 24% XXX 32% XXX XXX XXX
Bessemer Rule of X XXX XXX 49% XXX XXX XXX
Revenue per Employee XXX XXX $0.6M XXX XXX XXX
Opex per Employee XXX XXX $0.5M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 10% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 8% XXX XXX XXX
Opex to Revenue XXX XXX 73% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Almirall Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Almirall M&A and Investment Activity

Almirall acquired  XXX companies to date.

Last acquisition by Almirall was  XXXXXXXX, XXXXX XXXXX XXXXXX . Almirall acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Almirall

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Almirall

When was Almirall founded? Almirall was founded in 1944.
Where is Almirall headquartered? Almirall is headquartered in Spain.
How many employees does Almirall have? As of today, Almirall has 1.9K+ employees.
Who is the CEO of Almirall? Almirall's CEO is Mr. Carlos Gallardo Pique.
Is Almirall publicy listed? Yes, Almirall is a public company listed on MAD.
What is the stock symbol of Almirall? Almirall trades under ALM ticker.
When did Almirall go public? Almirall went public in 2007.
Who are competitors of Almirall? Similar companies to Almirall include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Almirall? Almirall's current market cap is $3.4B
What is the current revenue of Almirall? Almirall's last 12 months revenue is $1.3B.
What is the current revenue growth of Almirall? Almirall revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Almirall? Current revenue multiple of Almirall is 2.6x.
Is Almirall profitable? Yes, Almirall is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Almirall? Almirall's last 12 months EBITDA is $278M.
What is Almirall's EBITDA margin? Almirall's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Almirall? Current EBITDA multiple of Almirall is 12.1x.
What is the current FCF of Almirall? Almirall's last 12 months FCF is $107M.
What is Almirall's FCF margin? Almirall's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Almirall? Current FCF multiple of Almirall is 31.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.